Heart Disease Trial, Recruiting NCT05743140 Sponsor: Peking University First Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT05743140
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a coronary angiography (a special X-ray of the heart's blood vessels) performed at the Department of Cardiology, Peking University First Hospital
  • People whose medical records and background health information are complete
  • People whose coronary angiography results show that the narrowing in their heart's blood vessels is less than 50%
  • People who are older than 18 years of age
  • People who have signed a consent form agreeing to take part in the trial

Who may not be able to join:

  • People who have a serious eye condition affecting the back of the eye (retina)
  • People who have severe cataracts or other eye diseases that affect the quality of eye imaging
  • People where the blood vessel being examined supplies backup blood flow to another vessel that is completely blocked
  • People whose coronary angiography images are unclear due to poor dye filling, overlapping blood vessels, or significant distortion that prevents a clear view of any problem areas
  • People whose coronary angiography images are too low in quality to be properly read or interpreted
  • People who are currently experiencing active bleeding
  • People who have severe kidney problems, an allergy to the contrast dye used in coronary angiography, or who are otherwise unable to undergo coronary angiography

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bo Zheng, Dr, Peking University First Hospital

Phone: 13426046980

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peking University First Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
12 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic accuracy of fundus OCT and OCTA examinations for coronary microvascular disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov